{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:36:13Z","timestamp":1788572173096,"version":"build-2803163510"},"posted":{"date-parts":[[2026,4,16]]},"group-title":"Microbiology","reference-count":143,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Severe fever with thrombocytopenia syndrome virus (SFTSV) and Heartland virus (HRTV) are emerging tick-borne bandaviruses. They have high case fatality rates (10%), and no FDA-approved vaccines exist for disease prevention. SFTSV and HRTV are therefore identified as priority pathogens. A recombinant vesicular stomatitis virus (rVSV) vaccine, which replaces the original VSV glycoprotein with the SFTSV glycoproteins, shows early promise for SFTSV as it induces strong immune responses that are protective against lethal challenge. However, rVSV-SFTSV is highly attenuated in cell culture, which may be due to incompatibility between the assembly sites of SFTSV (the Golgi and ERGIC) and that of VSV (the plasma membrane).<\/jats:p>\n                <jats:p>\n                  In this study, we identify a noncanonical COPI binding motif found in the cytoplasmic tail of SFTSV glycoproteins and demonstrate that an amino acid substitution in this motif (K1071A) inhibits binding to COPI. This mutation results in increased surface expression of SFTSV glycoproteins, improved incorporation onto VSV virions, and enhanced replication of rVSV-SFSTV\n                  <jats:italic>in vitro.<\/jats:italic>\n                  A mutation in a homologous site (K1074A) of HRTV has similar results, and rVSV-HRTV K1074A exhibits increased replication\n                  <jats:italic>in vitro<\/jats:italic>\n                  and\n                  <jats:italic>in vivo<\/jats:italic>\n                  . We show that vaccination with rVSV-HRTV K1074A results in improved induction of neutralizing antibody responses in immunocompetent C57BL\/6 mice, and neutralizing antibodies elicited by vaccination are protective when administered to severely immunocompromised mice via passive transfer. Overall, our study identifies a mutation that improves the efficacy of the rVSV-SFTSV vaccine candidate and introduces the first vaccine candidate directly addressing HRTV infections.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Severe fever with thrombocytopenia syndrome virus (SFTSV) and Heartland bandavirus (HRTV) are emerging tick-borne viruses with high fatality rates. FDA-approved vaccines and antiviral drugs are unavailable but critically needed. We identify an important mutation in the SFTSV glycoprotein that disrupts a previously unreported COPI binding site. The mutation improves the efficacy of the previously described recombinant vesicular stomatitis virus vaccine candidate for SFTSV (rVSV-SFTSV). We also develop an rVSV-HRTV vaccine and show potent induction of neutralizing antibodies and protection from lethal challenge. This is the first study directly addressing the lack of vaccines specifically targeting HRTV.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.04.15.718665","type":"posted-content","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:10:13Z","timestamp":1776355813000},"source":"Crossref","is-referenced-by-count":2,"title":["Mutations that positively affect\n                  <i>Bandavirus<\/i>\n                  glycoprotein function on VSV vectored vaccines"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-4362","authenticated-orcid":false,"given":"Raegan J.","family":"Petch","sequence":"first","affiliation":[{"name":"Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-5692","authenticated-orcid":false,"given":"Philip","family":"Hicks","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-2980","authenticated-orcid":false,"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[{"name":"Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, 84322"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-2575","authenticated-orcid":false,"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[{"name":"Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, 84322"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-5976","authenticated-orcid":false,"given":"Paul","family":"Bates","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026042001200939000_2026.04.15.718665v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010095"},{"key":"2026042001200939000_2026.04.15.718665v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203378"},{"key":"2026042001200939000_2026.04.15.718665v1.3","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01069-24"},{"key":"2026042001200939000_2026.04.15.718665v1.4","doi-asserted-by":"crossref","unstructured":"Cui H , Shen S , Chen L , Fan Z , Wen Q , Xing Y , et al. Global epidemiology of severe fever with thrombocytopenia syndrome virus in human and animals: a systematic review and meta-analysis. Lancet Reg Health West Pac. 2024;48:101133.","DOI":"10.1016\/j.lanwpc.2024.101133"},{"key":"2026042001200939000_2026.04.15.718665v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00610-1"},{"key":"2026042001200939000_2026.04.15.718665v1.6","doi-asserted-by":"crossref","unstructured":"Bopp NE , Kaiser JA , Strother AE , Barrett ADT , Beasley DWC , Benassi V , et al. Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development. NPJ Vaccines. 2020;5:111.","DOI":"10.1038\/s41541-020-00257-5"},{"key":"2026042001200939000_2026.04.15.718665v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit603"},{"key":"2026042001200939000_2026.04.15.718665v1.8","doi-asserted-by":"publisher","DOI":"10.3201\/eid2604.191011"},{"key":"2026042001200939000_2026.04.15.718665v1.9","doi-asserted-by":"publisher","DOI":"10.3201\/eid1911.130792"},{"key":"2026042001200939000_2026.04.15.718665v1.10","doi-asserted-by":"publisher","DOI":"10.3201\/eid2011.140888"},{"key":"2026042001200939000_2026.04.15.718665v1.11","doi-asserted-by":"publisher","DOI":"10.3201\/eid2505.181463"},{"key":"2026042001200939000_2026.04.15.718665v1.12","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200104"},{"key":"2026042001200939000_2026.04.15.718665v1.13","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.190611"},{"key":"2026042001200939000_2026.04.15.718665v1.14","doi-asserted-by":"publisher","DOI":"10.3201\/eid2608.200135"},{"key":"2026042001200939000_2026.04.15.718665v1.15","doi-asserted-by":"crossref","unstructured":"Saba Villarroel PM , Chaiphongpachara T , Nurtop E , Laojun S , Pangpoo-Nga T , Songhong T , et al. Seroprevalence study in humans and molecular detection in Rhipicephalus sanguineus ticks of severe fever with thrombocytopenia syndrome virus in Thailand. Sci Rep. 2024;14:13397.","DOI":"10.1038\/s41598-024-64242-x"},{"key":"2026042001200939000_2026.04.15.718665v1.16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bsheal.2025.12.006","article-title":"SFTS exerts an underrecognized disease burden and socioeconomic effect in East Asia","volume":"8","year":"2026","journal-title":"Biosaf Health"},{"key":"2026042001200939000_2026.04.15.718665v1.17","doi-asserted-by":"crossref","unstructured":"Sun J , Lu L , Wu H , Yang J , Ren J , Liu Q. The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011-2016. Sci Rep. 2017;7:9236.","DOI":"10.1038\/s41598-017-08042-6"},{"key":"2026042001200939000_2026.04.15.718665v1.18","doi-asserted-by":"publisher","DOI":"10.3201\/eid2612.191513"},{"key":"2026042001200939000_2026.04.15.718665v1.19","doi-asserted-by":"crossref","unstructured":"Tsuru M , Suzuki T , Murakami T , Matsui K , Maeda Y , Yoshikawa T , et al. Pathological Characteristics of a Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected with SFTS Virus through a Sick Cat\u2019s Bite. Viruses. 2021;13.","DOI":"10.20944\/preprints202101.0207.v1"},{"key":"2026042001200939000_2026.04.15.718665v1.20","doi-asserted-by":"crossref","unstructured":"Kirino Y , Ishijima K , Miura M , Nomachi T , Mazimpaka E , Sudaryatma PE , et al. Seroprevalence of Severe Fever with Thrombocytopenia Syndrome Virus in Small-Animal Veterinarians and Nurses in the Japanese Prefecture with the Highest Case Load. Viruses. 2021;13.","DOI":"10.3390\/v13020229"},{"key":"2026042001200939000_2026.04.15.718665v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.10.006"},{"issue":"633","key":"2026042001200939000_2026.04.15.718665v1.22","first-page":"e1","article-title":"Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome","volume":"25","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026042001200939000_2026.04.15.718665v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ128"},{"key":"2026042001200939000_2026.04.15.718665v1.24","doi-asserted-by":"crossref","first-page":"e24502","DOI":"10.1016\/j.heliyon.2024.e24502","article-title":"A person-to-person transmission cluster of severe fever with thrombocytopenia syndrome characterized by mixed viral infections with familial and nosocomial clustering","volume":"10","year":"2024","journal-title":"Heliyon"},{"key":"2026042001200939000_2026.04.15.718665v1.25","doi-asserted-by":"crossref","unstructured":"Zheng W , Zhou H , Carr MJ , Shi W . Epidemic potential of SFTSV: increasing evidence for non-vector-borne transmission. Lancet Microbe. 2026;7:101271.","DOI":"10.1016\/j.lanmic.2025.101271"},{"key":"2026042001200939000_2026.04.15.718665v1.26","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.150126"},{"key":"2026042001200939000_2026.04.15.718665v1.27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imj.2021.10.001","article-title":"Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome","volume":"1","year":"2022","journal-title":"Infect Med (Beijing"},{"key":"2026042001200939000_2026.04.15.718665v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.09.009"},{"key":"2026042001200939000_2026.04.15.718665v1.29","unstructured":"NIAID. NIAID Biodefense Pathogens. 2024."},{"key":"2026042001200939000_2026.04.15.718665v1.30","unstructured":"CDC. Heartland Virus - Data and Maps for Heartland. US Centers for Disease Control and Prevention; 2024."},{"key":"2026042001200939000_2026.04.15.718665v1.31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/zoonoticdis3030016","article-title":"Heartland Virus: An Evolving Story of an Emerging Zoonotic and Vector-Borne Disease","volume":"3","year":"2023","journal-title":"Zoonotic Diseases"},{"key":"2026042001200939000_2026.04.15.718665v1.32","doi-asserted-by":"crossref","unstructured":"Dembek ZF , Mothershead JL , Cirimotich CM , Wu A . Heartland Virus Disease-An Underreported Emerging Infection. Microorganisms. 2024;12.","DOI":"10.3390\/microorganisms12020286"},{"key":"2026042001200939000_2026.04.15.718665v1.33","doi-asserted-by":"publisher","DOI":"10.3201\/eid2502.181288"},{"key":"2026042001200939000_2026.04.15.718665v1.34","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0702"},{"key":"2026042001200939000_2026.04.15.718665v1.35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4269\/ajtmh.18-0555","article-title":"Heartland Virus Exposure in White-Tailed Deer in the Southeastern United States, 2001-2015","volume":"99","year":"2018","journal-title":"Am J Trop Med Hyg."},{"key":"2026042001200939000_2026.04.15.718665v1.36","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.150380"},{"key":"2026042001200939000_2026.04.15.718665v1.37","doi-asserted-by":"crossref","unstructured":"Kim D , Lai CJ , Cha I , Jung JU . Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development. Viruses. 2024;16.","DOI":"10.3390\/v16010128"},{"key":"2026042001200939000_2026.04.15.718665v1.38","unstructured":"Elliott RM , Schmaljohn CS . Bunyaviridae. In: Knipe DM , Howley PM , editors. Fields Virology. Sixth edition. ed. Philadelphia, PA: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2013. p. 2 volumes (xx, 2456, I-82 pages)."},{"key":"2026042001200939000_2026.04.15.718665v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.06.007"},{"key":"2026042001200939000_2026.04.15.718665v1.40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02628-12"},{"key":"2026042001200939000_2026.04.15.718665v1.41","first-page":"7154","article-title":"Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion","volume":"113","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2026042001200939000_2026.04.15.718665v1.42","doi-asserted-by":"crossref","unstructured":"Zhang L , Peng X , Wang Q , Li J , Lv S , Han S , et al. CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Sci Adv. 2023;9:eadg6856.","DOI":"10.1126\/sciadv.adg6856"},{"key":"2026042001200939000_2026.04.15.718665v1.43","doi-asserted-by":"crossref","unstructured":"Zhu Y , Wu Y , Chai Y , Qi J , Peng R , Feng WH , et al. The Postfusion Structure of the Heartland Virus Gc Glycoprotein Supports Taxonomic Separation of the Bunyaviral Families Phenuiviridae and Hantaviridae. J Virol. 2018;92.","DOI":"10.1128\/JVI.01558-17"},{"key":"2026042001200939000_2026.04.15.718665v1.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006316"},{"key":"2026042001200939000_2026.04.15.718665v1.45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02141-13"},{"key":"2026042001200939000_2026.04.15.718665v1.46","doi-asserted-by":"crossref","first-page":"e1011232","DOI":"10.1371\/journal.ppat.1011232","article-title":"Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion","volume":"19","year":"2023","journal-title":"PLoS Pathog"},{"key":"2026042001200939000_2026.04.15.718665v1.47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2020.10.006","article-title":"Characterization of pseudotyped vesicular stomatitis virus bearing the heartland virus envelope glycoprotein","volume":"556","year":"2021","journal-title":"Virology"},{"key":"2026042001200939000_2026.04.15.718665v1.48","doi-asserted-by":"crossref","unstructured":"Wu X , Li Y , Huang B , Ma X , Zhu L , Zheng N , et al. A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo. JCI Insight. 2020;5.","DOI":"10.1172\/jci.insight.136855"},{"key":"2026042001200939000_2026.04.15.718665v1.49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705176114"},{"key":"2026042001200939000_2026.04.15.718665v1.50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007375"},{"key":"2026042001200939000_2026.04.15.718665v1.51","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00222-13"},{"key":"2026042001200939000_2026.04.15.718665v1.52","doi-asserted-by":"crossref","unstructured":"Shimojima M , Sugimoto S , Umekita K , Onodera T , Sano K , Tani H , et al. Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model. Viruses. 2022;14.","DOI":"10.3390\/v14081665"},{"key":"2026042001200939000_2026.04.15.718665v1.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05746-9"},{"key":"2026042001200939000_2026.04.15.718665v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11815-4"},{"key":"2026042001200939000_2026.04.15.718665v1.55","doi-asserted-by":"crossref","first-page":"e0007813","DOI":"10.1371\/journal.pntd.0007813","article-title":"Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice","volume":"14","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2026042001200939000_2026.04.15.718665v1.56","doi-asserted-by":"crossref","first-page":"e29203","DOI":"10.1002\/jmv.29203","article-title":"SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge","volume":"95","year":"2023","journal-title":"J Med Virol"},{"key":"2026042001200939000_2026.04.15.718665v1.57","doi-asserted-by":"crossref","first-page":"e0076924","DOI":"10.1128\/jvi.00769-24","article-title":"A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses","volume":"98","year":"2024","journal-title":"J Virol"},{"key":"2026042001200939000_2026.04.15.718665v1.58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","article-title":"mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice","volume":"8","year":"2023","journal-title":"NPJ Vaccines"},{"key":"2026042001200939000_2026.04.15.718665v1.59","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2014.0100"},{"key":"2026042001200939000_2026.04.15.718665v1.60","doi-asserted-by":"crossref","first-page":"e0186823","DOI":"10.1128\/mbio.01868-23","article-title":"Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets","volume":"14","year":"2023","journal-title":"mBio"},{"key":"2026042001200939000_2026.04.15.718665v1.61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bsheal.2021.12.008","article-title":"Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice","volume":"4","year":"2022","journal-title":"Biosaf Health"},{"key":"2026042001200939000_2026.04.15.718665v1.62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914704116"},{"key":"2026042001200939000_2026.04.15.718665v1.63","doi-asserted-by":"crossref","unstructured":"Dong F , Li D , Wen D , Li S , Zhao C , Qi Y , et al. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus. NPJ Vaccines. 2019;4:5.","DOI":"10.1038\/s41541-018-0096-y"},{"key":"2026042001200939000_2026.04.15.718665v1.64","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/vaccines12121403","article-title":"Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus","volume":"12","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026042001200939000_2026.04.15.718665v1.65","doi-asserted-by":"crossref","first-page":"109076","DOI":"10.1016\/j.vetmic.2021.109076","article-title":"A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice","volume":"257","year":"2021","journal-title":"Vet Microbiol"},{"key":"2026042001200939000_2026.04.15.718665v1.66","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1038\/s41598-023-35328-9","article-title":"Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV","volume":"13","year":"2023","journal-title":"Sci Rep"},{"key":"2026042001200939000_2026.04.15.718665v1.67","doi-asserted-by":"crossref","first-page":"e1008859","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","year":"2021","journal-title":"PLoS Pathog"},{"key":"2026042001200939000_2026.04.15.718665v1.68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/14760584.2023.2292772","article-title":"The use of electroporation to deliver DNA-based vaccines","volume":"23","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"2026042001200939000_2026.04.15.718665v1.69","doi-asserted-by":"crossref","unstructured":"Huang X , Li J , Li A , Wang S , Li D . Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome from 2010 to 2019 in Mainland China. Int J Environ Res Public Health. 2021;18.","DOI":"10.3390\/ijerph18063092"},{"key":"2026042001200939000_2026.04.15.718665v1.70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"2026042001200939000_2026.04.15.718665v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32621-6"},{"key":"2026042001200939000_2026.04.15.718665v1.72","doi-asserted-by":"crossref","unstructured":"Meakin S , Nsio J , Camacho A , Kitenge R , Coulborn RM , Gignoux E , et al. Effectiveness of rVSV-ZEBOV vaccination during the 2018-20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study. Lancet Infect Dis. 2024.","DOI":"10.2139\/ssrn.4812493"},{"key":"2026042001200939000_2026.04.15.718665v1.73","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.cmi.2023.08.026","article-title":"Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability","volume":"29","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026042001200939000_2026.04.15.718665v1.74","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1038\/s41467-024-51453-z","article-title":"Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases","volume":"15","year":"2024","journal-title":"Nat Commun"},{"key":"2026042001200939000_2026.04.15.718665v1.75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030002"},{"key":"2026042001200939000_2026.04.15.718665v1.76","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw218"},{"key":"2026042001200939000_2026.04.15.718665v1.77","doi-asserted-by":"crossref","first-page":"774026","DOI":"10.3389\/fimmu.2021.774026","article-title":"Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease","volume":"12","year":"2021","journal-title":"Front Immunol"},{"key":"2026042001200939000_2026.04.15.718665v1.78","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir298"},{"key":"2026042001200939000_2026.04.15.718665v1.79","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1995"},{"key":"2026042001200939000_2026.04.15.718665v1.80","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw256"},{"key":"2026042001200939000_2026.04.15.718665v1.81","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1165"},{"key":"2026042001200939000_2026.04.15.718665v1.82","doi-asserted-by":"crossref","first-page":"106237","DOI":"10.1016\/j.jinf.2024.106237","article-title":"Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-DeltaG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambarene, Gabon","volume":"89","year":"2024","journal-title":"J Infect"},{"key":"2026042001200939000_2026.04.15.718665v1.83","doi-asserted-by":"crossref","unstructured":"Navaratnarajah CK , Warrier R , Kuhn RJ . Assembly of Viruses: Enveloped Particles2008.","DOI":"10.1016\/B978-012374410-4.00667-1"},{"key":"2026042001200939000_2026.04.15.718665v1.84","doi-asserted-by":"crossref","first-page":"e0166013","DOI":"10.1371\/journal.pone.0166013","article-title":"Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn\/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"2026042001200939000_2026.04.15.718665v1.85","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.66.4.1907-1914.1992"},{"key":"2026042001200939000_2026.04.15.718665v1.86","doi-asserted-by":"crossref","unstructured":"Haferkamp S , Fernando L , Schwarz TF , Feldmann H , Flick R . Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins. Virol J. 2005;2:42.","DOI":"10.1186\/1743-422X-2-42"},{"key":"2026042001200939000_2026.04.15.718665v1.87","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0336"},{"key":"2026042001200939000_2026.04.15.718665v1.88","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.23.12200-12210.2002"},{"key":"2026042001200939000_2026.04.15.718665v1.89","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-12-3441"},{"key":"2026042001200939000_2026.04.15.718665v1.90","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(95)00006-C"},{"key":"2026042001200939000_2026.04.15.718665v1.91","doi-asserted-by":"crossref","first-page":"22565","DOI":"10.1016\/S0021-9258(17)31683-6","article-title":"A signal for Golgi retention in the bunyavirus G1 glycoprotein","volume":"269","year":"1994","journal-title":"J Biol Chem"},{"key":"2026042001200939000_2026.04.15.718665v1.92","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.19.10793-10802.2004"},{"key":"2026042001200939000_2026.04.15.718665v1.93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2013.09.023","article-title":"Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis","volume":"448","year":"2014","journal-title":"Virology"},{"key":"2026042001200939000_2026.04.15.718665v1.94","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00767-07"},{"key":"2026042001200939000_2026.04.15.718665v1.95","doi-asserted-by":"crossref","unstructured":"Spiegel M , Plegge T , Pohlmann S . The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release. Viruses. 2016;8.","DOI":"10.3390\/v8070202"},{"key":"2026042001200939000_2026.04.15.718665v1.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2012.10.017"},{"key":"2026042001200939000_2026.04.15.718665v1.97","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2013.41"},{"key":"2026042001200939000_2026.04.15.718665v1.98","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90105-0"},{"key":"2026042001200939000_2026.04.15.718665v1.99","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.112.142810"},{"key":"2026042001200939000_2026.04.15.718665v1.100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25589-1"},{"key":"2026042001200939000_2026.04.15.718665v1.101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s42003-022-03063-y","article-title":"An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking","volume":"5","year":"2022","journal-title":"Commun Biol"},{"key":"2026042001200939000_2026.04.15.718665v1.102","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14109"},{"key":"2026042001200939000_2026.04.15.718665v1.103","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.11.5913-5922.2004"},{"key":"2026042001200939000_2026.04.15.718665v1.104","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02146-06"},{"key":"2026042001200939000_2026.04.15.718665v1.105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M407233200"},{"key":"2026042001200939000_2026.04.15.718665v1.106","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02064-07"},{"key":"2026042001200939000_2026.04.15.718665v1.107","doi-asserted-by":"crossref","unstructured":"Hu Q , Zhang Y , Jiang J , Zheng A . Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step. Viruses. 2023;15.","DOI":"10.3390\/v15030800"},{"key":"2026042001200939000_2026.04.15.718665v1.108","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00132-24"},{"key":"2026042001200939000_2026.04.15.718665v1.109","doi-asserted-by":"crossref","unstructured":"Marques MC , Andreu-Moreno I , Sanjuan R , Elena SF , Geller R . An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins. Sci Rep. 2024;14:14644.","DOI":"10.1038\/s41598-024-65384-8"},{"key":"2026042001200939000_2026.04.15.718665v1.110","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02583-14"},{"key":"2026042001200939000_2026.04.15.718665v1.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.08.006"},{"key":"2026042001200939000_2026.04.15.718665v1.112","doi-asserted-by":"crossref","unstructured":"Manzoni TB , Westover JB , Lundgreen KA , Hicks PD , Petch RJ , Ort JT , et al. Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein. Viruses. 2025;17.","DOI":"10.3390\/v17081095"},{"key":"2026042001200939000_2026.04.15.718665v1.113","first-page":"e4690","article-title":"Cycloheximide (CHX) Chase Assay to Examine Protein Half-life","volume":"13","year":"2023","journal-title":"Bio Protoc"},{"key":"2026042001200939000_2026.04.15.718665v1.114","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089"},{"key":"2026042001200939000_2026.04.15.718665v1.115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2818.1993.tb03313.x"},{"key":"2026042001200939000_2026.04.15.718665v1.116","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"2026042001200939000_2026.04.15.718665v1.117","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14764"},{"key":"2026042001200939000_2026.04.15.718665v1.118","doi-asserted-by":"publisher","DOI":"10.2220\/biomedres.39.27"},{"key":"2026042001200939000_2026.04.15.718665v1.119","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2820"},{"key":"2026042001200939000_2026.04.15.718665v1.120","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0053-7"},{"key":"2026042001200939000_2026.04.15.718665v1.121","doi-asserted-by":"crossref","first-page":"22977","DOI":"10.1038\/s41598-021-01985-x","article-title":"Subcellular localization of nucleocapsid protein of SFTSV and its assembly into the ribonucleoprotein complex with L protein and viral RNA","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"2026042001200939000_2026.04.15.718665v1.122","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90148-5"},{"key":"2026042001200939000_2026.04.15.718665v1.123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36879-y"},{"key":"2026042001200939000_2026.04.15.718665v1.124","doi-asserted-by":"publisher","DOI":"10.1126\/science.8128252"},{"key":"2026042001200939000_2026.04.15.718665v1.125","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90011-6"},{"key":"2026042001200939000_2026.04.15.718665v1.126","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2002.6515"},{"key":"2026042001200939000_2026.04.15.718665v1.127","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-100818-125234"},{"key":"2026042001200939000_2026.04.15.718665v1.128","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/j.1460-2075.1993.tb05945.x","article-title":"beta\u2019-COP, a novel subunit of coatomer","volume":"12","year":"1993","journal-title":"EMBO J"},{"key":"2026042001200939000_2026.04.15.718665v1.129","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.7.4.631"},{"key":"2026042001200939000_2026.04.15.718665v1.130","doi-asserted-by":"crossref","unstructured":"Xu P , Hankins HM , MacDonald C , Erlinger SJ , Frazier MN , Diab NS , et al. COPI mediates recycling of an exocytic SNARE by recognition of a ubiquitin sorting signal. Elife. 2017;6.","DOI":"10.7554\/eLife.28342"},{"key":"2026042001200939000_2026.04.15.718665v1.131","doi-asserted-by":"crossref","unstructured":"Xie B , Guillem C , Date SS , Cohen CI , Jung C , Kendall AK , et al. An interaction between beta\u2019-COP and the ArfGAP, Glo3, maintains post-Golgi cargo recycling. J Cell Biol. 2023;222.","DOI":"10.1083\/jcb.202008061"},{"key":"2026042001200939000_2026.04.15.718665v1.132","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.8.4792-4796.1995"},{"key":"2026042001200939000_2026.04.15.718665v1.133","doi-asserted-by":"crossref","unstructured":"Baldon LVR , de Mendonca SF , Ferreira FV , Rezende FO , Amadou SCG , Leite T , et al. AG129 Mice as a Comprehensive Model for the Experimental Assessment of Mosquito Vector Competence for Arboviruses. Pathogens. 2022;11.","DOI":"10.3390\/pathogens11080879"},{"key":"2026042001200939000_2026.04.15.718665v1.134","doi-asserted-by":"crossref","unstructured":"Ramos-Cela M , Forconi V , Antonelli R , Manenti A , Montomoli E . Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity. Microorganisms. 2025;13.","DOI":"10.3390\/microorganisms13081785"},{"key":"2026042001200939000_2026.04.15.718665v1.135","doi-asserted-by":"crossref","first-page":"e0237323","DOI":"10.1128\/mbio.02373-23","article-title":"A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus","volume":"15","year":"2024","journal-title":"mBio"},{"key":"2026042001200939000_2026.04.15.718665v1.136","doi-asserted-by":"crossref","unstructured":"Slough MM , Chandran K , Jangra RK . Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors. mBio. 2019;10.","DOI":"10.1128\/mBio.02372-18"},{"key":"2026042001200939000_2026.04.15.718665v1.137","doi-asserted-by":"crossref","first-page":"117349","DOI":"10.1016\/j.bcp.2025.117349","article-title":"Precision vaccine design targeting the prefusion state of viral glycoproteins: advances in structural vaccinology","volume":"242","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"2026042001200939000_2026.04.15.718665v1.138","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826"},{"key":"2026042001200939000_2026.04.15.718665v1.139","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28931-3"},{"key":"2026042001200939000_2026.04.15.718665v1.140","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03412.x"},{"key":"2026042001200939000_2026.04.15.718665v1.141","doi-asserted-by":"publisher","DOI":"10.1038\/nri3787"},{"key":"2026042001200939000_2026.04.15.718665v1.142","doi-asserted-by":"publisher","DOI":"10.3201\/eid2212.160472"},{"key":"2026042001200939000_2026.04.15.718665v1.143","doi-asserted-by":"crossref","unstructured":"Fujii H , Tani H , Egawa K , Taniguchi S , Yoshikawa T , Fukushi S , et al. Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV. Viruses. 2022;14.","DOI":"10.3390\/v14081668"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.04.15.718665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:20:47Z","timestamp":1776673247000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.04.15.718665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":143,"URL":"https:\/\/doi.org\/10.64898\/2026.04.15.718665","relation":{},"subject":[],"published":{"date-parts":[[2026,4,16]]},"subtype":"preprint"}}